Enhancing anti-tumor immunity through co-blocking PD-L1 and TIGIT by facilitating tumor-directed responses and additional VEGF inhibition.

Overall, PD-L1 expression correlated positively with CD4 + and CD8 + T-cell density, whereas CD155 exhibited a negative trend with CD8 + T-cell infiltration ( Figure 6H ).

also in 4,201 other papers